BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
2/18/2019 3:14:49 AM | Browse: 1268 | Download: 2613
 |
Received |
|
2018-10-05 07:51 |
|
Peer-Review Started |
|
2018-10-06 00:18 |
|
First Decision by Editorial Office Director |
|
2018-11-15 23:21 |
|
Return for Revision |
|
2018-11-21 03:18 |
|
Revised |
|
2018-12-14 18:41 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2018-12-29 03:19 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2018-12-30 02:47 |
|
Articles in Press |
|
2018-12-30 02:47 |
|
Edit the Manuscript by Language Editor |
|
2019-01-22 18:15 |
|
Typeset the Manuscript |
|
2019-02-11 06:29 |
|
Publish the Manuscript Online |
|
2019-02-18 03:14 |
| ISSN |
1948-9358 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Endocrinology & Metabolism |
| Manuscript Type |
Systematic Reviews |
| Article Title |
SGLT-2 inhibitors in non-alcoholic fatty liver disease patients with type 2 diabetes mellitus: A systematic review
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Henith Raj, Harsh Durgia, Rajan Palui, Sadishkumar Kamalanathan, Sandhiya Selvarajan, Sitanshu Sekhar Kar and Jayaprakash Sahoo |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Jayaprakash Sahoo, MD, Associate Professor, Department of Endocrinology, Jawaharlal Institute of Postgraduate Medical Education and Research, Room No. 5444, the 4th Floor, Superspeciality block, Pondicherry 605006, India. jayaprakash.s@jipmer.edu.in |
| Key Words |
Alanine aminotransferase; Hepatic fat; Hepatic fibrosis; Non-alcoholic fatty liver disease; Sodium-glucose cotransporter-2 inhibitor; Type 2 diabetes mellitus |
| Core Tip |
The frequent coexistence of non-alcoholic fatty liver disease (NAFLD) and type 2 diabetes, their adverse health consequences, and lack of adequate therapeutic options makes it necessary to search for newer alternatives. Currently, pioglitazone and vitamin E are recommended in addition to lifestyle modifications for the management of NAFLD. Animal studies have shown that sodium glucose cotransporter-2 inhibitors might be beneficial in NAFLD present in diabetes patients. The current systematic review shows that sodium glucose cotransporter-2 inhibitors improve the serum level of liver enzymes, liver fat, and liver fibrosis with additional beneficial effects on various metabolic parameters in type 2 diabetes patients with NAFLD. |
| Publish Date |
2019-02-18 03:14 |
| Citation |
Raj H, Durgia H, Palui R, Kamalanathan S, Selvarajan S, Kar SS, Sahoo J. SGLT-2 inhibitors in non-alcoholic fatty liver disease patients with type 2 diabetes mellitus: A systematic review. World J Diabetes 2019; 10(2): 114-132 |
| URL |
https://www.wjgnet.com/1948-9358/full/v10/i2/114.htm |
| DOI |
https://dx.doi.org/10.4239/wjd.v10.i2.114 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
